Concepedia

Author

Tomoyo Sakata‐Kato

Harvard UniversityORCID

Also Known As

Sakata-Kato, Tomoyo, Tomoyo Sakata-Kato, Tomoyo Sakata‐Kato

22

Publications

1.2K

Citations

14

H-Index

27

Concepts

All Affiliations

Harvard UniversityBroad InstituteUniversity of California San DiegoGlaxoSmithKline (Spain)Washington University in St. Louis
TS

About

Tomoyo Sakata‐Kato is an author at Harvard University specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

381

2

Natural Sciences

2

2

332

3

Biochemistry

2

2

106

4

Biomolecular Engineering

1

1

35

5

Cell Biology

1

1

14

Tomoyo Sakata‐Kato

×

14

Publications

1.2K

Citations

14

H-Index

YearCitations

Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics

Annie N. Cowell, Eva S. Istvan, Amanda K. Lukens,

Science

2018

269

Diversity-oriented synthesis yields novel multistage antimalarial inhibitors

Nobutaka Kato, Eamon Comer, Tomoyo Sakata‐Kato,

Nature

2016

261

Open-source discovery of chemical leads for next-generation chemoprotective antimalarials

Yevgeniya Antonova‐Koch, Stephan Meister, Matthew Abraham,

Science

2018

136

A broad analysis of resistance development in the malaria parasite

Victoria Corey, Amanda K. Lukens, Eva S. Istvan,

Nature Communications

2016

129

Control of inflammation by stromal Hedgehog pathway activation restrains colitis

John J. Lee, Michael E. Rothenberg, E. Scott Seeley,

Proceedings of the National Academy of Sciences

2016

89

Structural Basis for Blocking Sugar Uptake into the Malaria Parasite Plasmodium falciparum

Xin Jiang, Yafei Yuan, Jian Huang,

Cell

2020

71

A Novel Methodology for Bioenergetic Analysis of <i>Plasmodium falciparum</i> Reveals a Glucose-Regulated Metabolic Shift and Enables Mode of Action Analyses of Mitochondrial Inhibitors

Tomoyo Sakata‐Kato, Dyann F. Wirth

ACS Infectious Diseases

2016

35

In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection model

Rebecca Mandt, María José Lafuente-Monasterio, Tomoyo Sakata‐Kato,

Science Translational Medicine

2019

35

Orthosteric–allosteric dual inhibitors of PfHT1 as selective antimalarial agents

Jian Huang, Yafei Yuan, Na Zhao,

Proceedings of the National Academy of Sciences

2021

32

The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance

James M. Murithi, Ioanna Deni, Charisse Flerida A. Pasaje,

Cell chemical biology

2021

27

Page 1